MENU
BLRX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
BioLineRx (BLRX) Ownership - Who owns BioLineRx?
BioLine Rx Ltd is a commercial-stage biopharmaceutical company focused on oncology... Show more
Industry: #Pharmaceuticals Other
Profile
Industry
Pharmaceuticals Other
Address
2 HaMa’ayan Street
Phone
+972 86429100
Employees
79
Web
https://www.biolinerx.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
14.2M
P/E Ratio
N/A
Total Cash
26.37M
Projected Growth
N/A
Total Debt
13.74M
Revenue
22.34M
Risk (Beta)
1.23
Dividend Yield
N/A
Total Cash/Share
7.09
Total Debt/Equity
N/A
Revenue/Share
9.05 USD as % of share price
Fundamentals
BLRX
Capitalization
14.2M
P/E Ratio
N/A
Risk (Beta)
1.23
Dividend Yield
N/A
Total Cash
26.4M
Total Cash/Share
7.09
Total Debt
13.7M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
9.05%
Revenue
22.3M
ROE
N/A
Book Value
20.9M
P/B Ratio
0.65
Cash Flow
N/A
Earnings
-6
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
62.6M
Current Ratio
2.27
Current Revenue Per Employee
9107.14
Dividends Per Share - Security
N/A
EBITDA
8.5M
Float
N/A
Float - Current
N/A
Gross Income Margin
86.67
Revenue To Assets
-7.15
Shares Held By Institutions
27.2K
Shares Outstanding - Current
3.72M
Total Liabilities
22.6M
Total Volume MTD
N/A
Value
1
Gain YTD
-57.360
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period.
A.I. Advisor
published General Information
General Information
a clinical-stage biopharmaceutical development company
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
2 HaMa’ayan Street
Phone
+972 86429100
Employees
79
Web
https://www.biolinerx.com